First, Last Name DOB: Maternal Risk Questionnaire (MRQ)

Similar documents
First, Last Name: DOB: F91148 Maternal Risk Questionnaire

Cord Blood Medical History/ Health Assessment Questionnaire

FORM TITLE: Risk Behavior Assessment. 1. Are you a male who has had sex with another male in the preceding five years?

PUBLIC HEALTH UPDATE

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators

מדינת ישראל. Tourist Visa Table

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

SLV Health Blood Drive

Regional Update Pandemic (H1N1) 2009

Question: 1. Are you currently taking an antibiotic?

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

DHQ Flowcharts v2.0 eff. February 2016

Zika virus transmission: ECDC adaptation of WHO's Zika virus country classification scheme 1

Terms and Conditions. VISA Global Customer Assistance Services

Regional Update Pandemic (H1N1) 2009

DHQ v2.0, February 2016 Table Detailing Changes from v1.3 v1.3 Revised language in v2.0 Rationale Question 1: Are you

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

THE CARE WE PROMISE FACTS AND FIGURES 2017

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

Question: 1. Are you currently taking an antibiotic?

Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas

Eligibility List 2018

Annex 2 A. Regional profile: West Africa

ZIKA VIRUS WHAT IS THE SITUATION IN SINGAPORE? 6 September 2016

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

UNOS # NA. Person(s) Interviewed (First and last name) Relationship(s) to him/her. Print Name Title Signature

Regional Update Pandemic (H1N1) 2009 (January 19, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST)

Hepatitis B and C Basics

Main developments in past 24 hours

3.5 Consumption Annual Prevalence Opiates

FRAMEWORK CONVENTION ALLIANCE BUILDING SUPPORT FOR TOBACCO CONTROL. Smoke-free. International Status Report

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Regional Update Pandemic (H1N1) 2009 (July 31, h GMT; 17 h EST) Update on the Qualitative Indicators Epidemiological Week 29 intensity

Regional Update Pandemic (H1N1) 2009 (December 1, h GMT; 12 h EST)

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

ANNEX 3: Country progress indicators

ADMINISTRATIVE AND FINANCIAL MATTERS. Note by the Executive Secretary * CONTENTS. Explanatory notes Tables. 1. Core budget

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

This also applies to all travellers transiting through countries with risk of transmission of yellow fever.

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

World Health Organization Department of Communicable Disease Surveillance and Response

countries do not have information available for this indicator.

Not Under Document Control If Printed. Donor Educational Materials. If you are deferred

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Epidemiology and Response Datapack

Supplementary appendix

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

Zika Virus. Public Information Update/phone script. Date: March 28, 2016 Time: 11:00 a.m.

Donor Risk Assessment Interview (Donor >12 yrs old)

Maternal Deaths Disproportionately High in Developing Countries

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #:

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Special Topic. The ten leading causes of death in countries of the Americas

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

WHO report highlights violence against women as a global health problem of epidemic proportions

HEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #:

OVERVIEW OF THE POLIO ERADICATION AND ENDGAME STRATEGIC PLAN AND THE topv TO bopv SWITCH

Epidemiological Estimates for Haemoglobin Disorders: WHO South East Asian Region by Country

Calls from home residential tariffs

Tipping the dependency

Why Invest in Nutrition?

Uniform Donor Risk Assessment Interview (Donor >12 yrs old)

GLOBAL RepORt UNAIDS RepoRt on the global AIDS epidemic

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

Everything you ever wanted to know about Zika Virus Disease

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

TOBACCO USE PREVALENCE APPENDIX II: The following definitions are used in Table 2.1 and Table 2.3:

Tobacco: World Markets and Trade

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

ABO: Tissue#:

NON-STANDARD PRICE GUIDE FOR EE SMALL BUSINESS More information about out-of-bundle charges for our small business customers

we are daisy Daisy Conferencing Max Bridge charges* International charges* International toll-free access levy

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Epidemiological Estimates for Haemoglobin Disorders: The World by WHO Region

STAT/SOC/CSSS 221 Statistical Concepts and Methods for the Social Sciences. Introduction to Mulitple Regression

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME

Hot Topics in Tissue Safety

ICM: Trade-offs in the fight against HIV/AIDS

Directed Semen Donor Eligibility Requirements

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

World Pre-trial / Remand Imprisonment List

Pacific Telecom Inc. (PTI) Message Telecommunications Service Table of General Rates

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD

Acute Public Health Events Assessed by WHO Regional Offices for Africa, the Americas, and Europe under the International Health Regulations (2005)

Figure 1: Case Distribution of Dengue Hemorrhagic Fever, in %, by subregion, *This includes cases of dengue with complications.

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries

Transcription:

First, Last Name DOB: Cord Blood Bank Use Only: Maternal Risk Questionnaire (MRQ) NMDP CBU ID: Local CBU ID: NMDP Maternal ID: Local Maternal ID: Today's Date: Baby's Mother's Initials: Please read questions carefully and answer to the best of your knowledge: 1. Have you every donated or attempted to donate cord blood using your current, or a different name, to this cord blood bank? 2. Have you, for any reason, been deferred or refused as a blood or cord blood donor, or been told not to donate blood or cord blood? If yes, why? 3. Have you taken any of the following medications (check all that apply). a. Insulin from cows (bovine or beef insulin) since 1980? b. Growth hormone from human pituitary glands ever? c. Rabies vaccination in the past year? d. Hepatitis B Immune Globulin following an exposure to Hepatitis B? 4. In the past 8 weeks, have you had any shots or vaccinations? If yes, please describe: 5. In the past 12 weeks, have you had physical contact with someone who has received the smallpox vaccine? (Examples of contact include intimacy, touching the vaccination site, touching the bandages or covering of the vaccination site, or handling bedding or clothing that had been in contact with an unbandage vaccination site.) 1

6. In the past 4 months, have you experienced two or more of the following: a fever (>100.5 F or 38.06 C), headache, muscle weakness, skin rash on trunk of the body, or swollen lymph glands? If yes, which symptoms and when? 7. Have you ever had any type of cancer, including leukemia? 8. In the past 5 years, have you had a bleeding problem, such as hemophilia or other clotting factor deficiencies, and received human-derived clotting factor concentrates? 9. During your pregnancy, have you been diagnosed with West Nile Virus or had a positive test for West Nile Virus? 10. Have you had a past diagnosis of clinical, symptomatic viral hepatitis after age 11? 11. Have you ever had a parasitic blood disease (for example, Leishmaniasis, Babesiosis, or Chagas disease) or any positive tests for Chagas or T. cruzi, including screening tests? 12. Have you ever been diagnosed with Creutzfeldt-Jakob Disease (CJD), variant CJD, dementia, any degenerative or demyelinating disease of the central nervous system, or other neurological disease where the cause is unknown? 13. Have any of your blood relatives ever been diagnosed with Creutzfeldt-Jakob Disease (CJD), or have you been told that your family has an increased risk for this disease? 14. Have you received a dura mater (brain covering) graft? 15. Have you ever had a transplant or other medical procedure that involved being exposed to live cells, tissues, or organs from an animal? 16. Have you ever lived with, or had sexual contact with, anyone who had a transplant or other medical procedure that involved being exposed to live cells, tissues, or organs from an animal? In the past 3 years: 17. Have you had malaria? 18. Have you been outside the United States or Canada? If yes, please list where, when, and for how long: 19. In the 12 months prior to collection of the cord blood unit, have you had a blood transfusion? In the past 12 months: 20. Have you had a transplant or tissue graft from someone other than yourself, such as organ, bone marrow, stem cell, cornea, bone, skin, or other tissue? 21. Have you had a tattoo or ear, skin, or body piercing? If yes, answer question 22. If no, skip to question 23. 22. Were shared or non-sterile inks, needles, instruments, or procedures used for the tattoo or piercing? 2

23. Have you had an accidental needle stick or have you come into contact with someone else's blood through an open wound (for example, a cut or sore), non-intact skin, or mucous membrane (for example, into your eye, mouth, etc.)? 24. Have you had or been treated for a sexually transmitted disease, including syphilis? 3 25. Have you given money or drugs to anyone to engage in sex with you? In the past 12 months continued: 26. Have you engaged in sex with anyone who had taken money or drugs for sex in the past 5 years? 27. Have you had sexual contact or lived with a person who has active or chronic viral Hepatitis B or Hepatitis C? 28. Have you had sex, even once, with anyone who has used a needle to take drugs, steroids, or anything else not prescribed by a doctor in the past 5 years? 29. Have you had sex with a male who has had sex with another male, even once, in the past 5 years? 30. Have you had sex, even once, with anyone who has taken human-derived clotting factors for a bleeding problem in the past 5 years? 31. Have you had sex, even once, with anyone who has HIV/AIDS or has had a positive test for the AIDS virus? 32. Have you been in juvenile detention, lockup, jail, or prison for more than 72 continuous hours? In the past 5 years: 33. Have you engaged in sex in exchange for money or drugs? 34. Have you used a needle, even once, to take drugs, steroids, or anything else not prescribed for you by a doctor? 35. Do you have AIDS or have you ever tested positive for HIV (including screening tests)? 36. Do you have any of the following: a. Unexplained night sweats? b. Blue or purple spots on or under the skin or mucous membranes typical of Kaposi's sarcoma? c. Unexplained weight loss? d. Unexplained persistent diarrhea? e. Unexplained cough or shortness of breath? f. Unexplained temperature higher than 100.5 F (38.06 C) for more than 10 days? g. Unexplained persistent white spots or sores in the mouth? h. Multiple lumps in your neck, armpits, or groin lasting more than one month? i. Any infections during your pregnancy?

37. Have you ever tested positive for HTLV (including screening tests) or had unexplained paraparesis (partial paralysis affecting the lower limbs)? HTLV refers to Human T-cell Lymphotropic Virus 38. Do you understand that if a person has the AIDS virus and feels well and has a negative AIDS test, he/she can still give it to someone else? For questions 39 through 48, please refer to the charts below for a list of countries involved: Reference Guide for Questions 39 & 42: Countries Considered to be at Risk for Transmission of vcjd Albania Austria Belgium Bosnia-Herzegovina Bulgaria Croatia Czech Republic Denmark Finland France Germany Greece Hungary Ireland (Republic of) Italy Liechtenstein Luxembourg Macedonia Netherlands (Holland) Norway Poland Portugal Romania Slovak Republic Slovenia Spain Sweden Switzerland United Kingdom: England, Northern Ireland, Scotland, Wales, The Isle of Man, The Channel Islands, Gibraltar or The Falkland Islands Yugoslavia (Federal Republic of): Kosovo, Montenegro, Serbia 39. Since 1980, have you ever lived in or traveled to any country considered to be at risk for transmission of vcjd (variant Creutzfeldt-Jakob disease)? (refer to chart) If yes, answer questions 40 through 42. If no, skip to question 43. 40. From 1980 through 1996, did you spend time that adds up to 3 months or more in the United Kingdom (England, Northern Ireland, Scotland, Wales, the Isle of Man, the Channel Islands, Gibraltar, or the Falkland Islands)? 41. Since 1980, have you received a transfusion of blood or blood components while in the UK or France? 42. Since 1980, have you spent time that adds up to 5 years or more (including time spent in the UK between 1980 and 1996) in any country considered to be at risk for transmission of vcjd (variant Creutzfeldt-Jakob Disease)? (refer to chart) 43. From 1980 through 1996, were you a member of the U.S. military, a civilian military employee, or a dependent of either a member of the U.S. military or civilian military employee? 44. From 1980 through 1990, did you spend a total of 6 months or more associated with a military base in any of the following countries: United Kingdom, Belgium, Netherlands, or Germany? 45. From 1980 through 1996, did you spend a total of 6 months or more associated with a military base in any of the following countries: Spain, Portugal, Turkey, Italy, or Greece? 4

Reference Guide for Questions 46-48: African Countries Considered to be at Risk for Transmission for HIV-1 Group O Benin Cameroon Central African Republic Chad Congo Equatorial Guinea Gabon Kenya Niger Nigeria Senegal Togo Zambia 46. Since 1977, were you born in, have you lived for longer than one year in, or have you traveled to any African country considered to be at risk for transmission of HIV-1 group O? (refer to chart) If yes, answer question 47. If no, skip to question 48. 47. While in one of the African countries listed in the chart, did you receive a blood transfusion or any other medical treatment with a product made from blood? 48. Have you had sexual contact with anyone who was born in or lived in any African country listed in the chart since 1977? March 2016 Final Guidance Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissue, and Cellular and Tissue-Based Products we are required to ask about Zika exposure. In the past 6 months, have you 49. Had Zika Virus infection? 50. Lived or traveled to an area with active Zika Virus transmission? (See List) 51. Had sexual contact with a man, who in the 6 months prior to sexual contact, has had the Zika Virus infection or lived in or traveled to an area with active Zika Virus transmission? Verified By: Date: Donor has completed this form to the best of their knowledge Cord Blood Donor: Date: 5

All Countries & Territories with Active Zika Virus Transmission Anguilla Antigua and Barbuda Argentina Aruba The Bahamas Barbados Belize Bolivia Bonaire Brazil British Virgin Islands Cayman Islands Colombia Commonwealth of Puerto Rico, US territory Costa Rica Cuba Curacao Dominica Dominican Republic Ecuador El Salvador French Guiana Grenada Guadeloupe Guatemala Guyana Haiti Honduras Jamaica Martinique Mexico Montserrat Nicaragua Panama Paraguay Peru Saba Saint Barthélemy Saint Lucia Saint Martin Saint Vincent and the Grenadines Saint Eustatius Saint Maarten St. Kitts and Nevis Suriname Trinidad and Tobago Turks and Caicos United States U.S. Virgin Islands Venezuela American Samoa Fiji Federated States of Micronesia Marshall Islands New Caledonia Palau Papua New Guinea Samoa Singapore Tonga Cape Verde Other Countries with Endemic Zika Some countries in Africa, the Pacific Islands, and Asia have reported Zika in the past and may report occasional new cases. The risk to travelers in these endemic countries is likely much lower than it is in countries with Zika outbreaks (see Q&A: Zika Risk in Countries with Endemic Zika). Because Zika infection in a pregnant woman can cause severe birth defects, pregnant women should consult with their health care provider and, if they decide to travel, should strictly follow steps to prevent mosquito bites during the trip. Travel notices have not been issued for these destinations but would be considered if the number of cases rises to the level of an outbreak. Check this page for the most up-to-date information before you make travel plans. Africa: Angola, Benin, Burkina-Faso, Cameroon, Central African Republic, Côte d Ivoire, Egypt, Ethiopia, Gabon, Guinea-Bissau, Kenya, Liberia, Mali, Mozambique, Niger, Nigeria, Senegal, Sierra Leone, Somalia, Tanzania, Togo, Uganda, Zambia Asia: Bangladesh, India, Pakistan The Pacific Islands: Easter Island, Vanuatu 3/10/2017 https://www.cdc.gov/zika/geo/active-countries.html 6